Greenleaf Trust »

Alterity Therapeutics shares owned by Greenleaf Trust

Quarter-by-quarter ownership of Alterity Therapeutics (ATHE) shares owned by Greenleaf Trust from 13F filings

Historical chart of Greenleaf Trust investment in Alterity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alterity Therapeutics held by Greenleaf Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alterity Therapeutics by Greenleaf Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $120k 32k 3.76
2025-06-30 $70k 17k 4.09

More positions owned by Greenleaf Trust

Stryker Corporation (SYK)
iShares S&P 500 Index (IVV)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Apple (AAPL)
Microsoft Corporation (MSFT)
iShares S&P MidCap 400 Index (IJH)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
iShares S&P SmallCap 600 Index (IJR)
iShares MSCI Emerging Markets Indx (EEM)
Alphabet Inc Class C cs (GOOG)
Visa (V)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Berkshire Hathaway (BRK.B)

View all positions for Greenleaf Trust

Top funds holding Alterity Therapeutics

Twin Lakes Capital Management
HB Wealth Management
Morgan Stanley
Greenleaf Trust
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Acadian Asset Management
Rhumbline Advisers
Advisor Group Holdings
EverSource Wealth Advisors
Ronald Blue Trust
Farther Finance Advisors
Steward Partners Investment Advisory
Danske Bank A/s
SBI Securities

View all funds holding Alterity Therapeutics